Recor Medical · 2 hours ago
Therapy Development Territory Manager - FL(Panhandle)/TN/AL
Maximize your interview chances
Health CareMedical
Insider Connection @Recor Medical
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Determine where our therapies can assist in providing an adjunctive hypertension management solution.
Identify key referral networks for renal denervation therapy – across multiple provider types.
Develop and enhance these relationships through therapy awareness activities, routine customer visits, product demonstrations, educational programs, procedural observation, trade show participation and problem resolution.
Educate physicians and AHPs on the merits and proper incorporation of company products by giving presentations and demonstrations.
Work closely with the Territory Management and Clinical Site Management in evaluating patient care pathway conditions.
Identify shared priorities and leverage knowledge and tactics within the full account to develop a strategic territory business plan that drives product demand by meeting the needs of key partners and ultimately their patients to drive superior results.
Analyze existing referral trends to gain insights into the local healthcare network, drive pull-through and lead virtual and / or live engagements with customers.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s degree and 5+ years of sales experience, including 2+ years’ experience in a clinical or sales healthcare/pharmaceutical environment
Existing relationships within geography PCP, Cardiology, Nephrology or other hypertension management offices or direct knowledge of physicians and clinicians in the therapy market
Candidates must reside in the listed territory
Company
Recor Medical
ReCor Medical has developed a unique therapeutic non-focused ultrasound system
Funding
Current Stage
Late StageTotal Funding
$25MKey Investors
Otsuka Holdings
2018-07-10Acquired
2016-06-10Debt Financing· $10M
2015-04-13Series D· $15M
Recent News
Company data provided by crunchbase